Mativ Holdings, Inc. (MATV) - Q2 2024 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended June 30, 2024. Mativ Holdings, Inc. is a global leader in specialty materials, operating through two reportable segments following a Q1 2024 organizational realignment: Filtration & Advanced Materials (FAM) and Sustainable & Adhesive Solutions (SAS). The Engineered Papers (EP) business was divested in November 2023 and is reported as a discontinued operation.
Key Financial Metrics
| Metric (in millions) | Q2 2024 | Q2 2023 | YTD 2024 | YTD 2023 |
|---|---|---|---|---|
| Net Sales | $523.8 | $526.5 | $1,024.0 | $1,075.5 |
| Gross Profit | $108.9 | $95.5 | $192.9 | $183.2 |
| Gross Margin | 20.8% | 18.1% | 18.8% | 17.0% |
| Operating Profit (Loss) | $10.5 | $10.4 | $(3.3) | $8.2 |
| Net Loss (Continuing Ops) | $(1.4) | $(14.3) | $(29.4) | $(29.8) |
| Diluted EPS (Continuing Ops) | $(0.03) | $(0.26) | $(0.54) | $(0.55) |
| Operating Cash Flow (YTD) | $33.1 | $5.5 | $33.1 | $5.5 |
| Total Debt | $1,136.4 | N/A | $1,136.4 | N/A |
| Cash & Equivalents | $133.4 | N/A | $133.4 | N/A |
Material Changes vs. Prior Period
- Revenue: Q2 net sales decreased 0.5% year-over-year. YTD sales declined 4.8%, driven by lower volumes in advanced films and lower selling prices due to input cost deflation, partially offset by higher filtration volumes.
- Profitability: Gross margin expanded to 20.8% in Q2 (from 18.1% in Q2 2023) due to favorable net selling price versus input cost performance. However, YTD operating loss of $3.3 million contrasts with a $8.2 million profit in the prior year, primarily due to significant restructuring charges.
- Restructuring & Impairment: Expenses surged to $11.8 million in Q2 (vs. $0.5 million in Q2 2023) and $26.2 million YTD (vs. $1.3 million). This includes $7.2 million in asset impairments at the Eerbeek, Netherlands facility and $15.7 million in severance charges related to an organizational realignment plan.
- Interest Expense: Increased to $18.4 million in Q2 (up 12.2% YoY) due to higher average interest rates and debt balances.
Guidance, Outlook, and Risks
- Outlook: Management expects restructuring activities associated with the realignment plan to be completed in 2024, with additional costs not expected to exceed $1.0 million. The company anticipates remaining in compliance with financial covenants (Net Debt/EBITDA max 4.50x; currently 4.1x).
- Liquidity: The company holds $133.4 million in cash and has $302.6 million of undrawn capacity on its $600.0 million revolving credit facility. A quarterly dividend of $0.10 per share was declared.
- Risks: Key risks include supply chain disruptions, inflationary pressures on operating costs, currency exchange rate fluctuations (specifically Euro weakness), and the impact of global conflicts on trade and demand. The company is also monitoring the implementation of Pillar Two tax legislation.
Investor Verification Checklist
- Restructuring Execution: Verify the timeline and cost savings realization from the organizational realignment plan and the Eerbeek facility closure.
- Asset Impairment: Review the long-term cash flow assumptions used for the $7.2 million impairment charge at the Netherlands facility.
- Debt Servicing: Monitor the impact of rising interest rates on the weighted average effective interest rate (currently ~6.10%) and future interest expense.
- Volume Trends: Assess the sustainability of volume growth in the Filtration segment versus the decline in Advanced Films.
- Covenant Compliance: Confirm continued adherence to the 4.50x Net Debt to EBITDA covenant given the current leverage of 4.1x.